Blocking the CD47-SIRPα Axis enhances Tafasitamab-mediated phagocytosis

被引：0

作者：

Biedermann, A. ^{[1
]}

Mangelberger-Eberl, D. ^{[2
]}

Mougiakakos, D. ^{[3
]}

Buettner-Herold, M. ^{[4
]}

Patra-Kneuer, M. ^{[2
]}

Flamann, C. ^{[1
]}

Kellner, C. ^{[5
]}

Peipp, M. ^{[6
]}

Altmeyer, S. ^{[7
]}

Bittenbring, J. ^{[7
]}

Augsberger, C. ^{[2
]}

Landgraf, K. ^{[2
]}

Ilieva-Babinsky, K. ^{[2
]}

Hasskamp, S. ^{[8
,9
]}

Beier, F. ^{[10
]}

Lischer, C. ^{[11
]}

Vera, J. ^{[11
]}

Voelkl, S. ^{[1
]}

Jacobs, B. ^{[1
]}

Steidl, S. ^{[2
]}

Heitmueller, C. ^{[2
]}

Mackensen, A. ^{[1
]}

Bruns, H. ^{[1
]}

机构：

[1] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med Hematol & Oncol 5, Erlangen, Germany

[2] MophoSys AG, Munich, Germany

[3] Otto von Guericke Univ, Dept Hematol & Oncol, Magdeburg, Germany

[4] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephropathol, Erlangen, Germany

[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Div Transfus Med Cell Therapeut & Haemostaseol, Munich, Germany

[6] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Kiel, Germany

[7] Saarland Univ, Med Klin 1, Med Sch, Homburg, Germany

[8] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany

[9] Inst Human Genet, Erlangen, Germany

[10] RWTH Med Sch, Dept Oncol Hematol & Stem Cell Transplantat, Aachen, Germany

[11] Friedrich Alexander Univ Erlangen Nurnberg, Dept Dermatol, Erlangen, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P762

引用

页码：269 / 269

页数：1

共 50 条

[31] CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells
Martinez-Sanz, Paula
Hoogendijk, Arjan J.
Verkuijlen, Paul J. J. H.
Schornagel, Karin
van Bruggen, Robin
van den Berg, Timo K.
Tytgat, Godelieve A. M.
Franke, Katka
Kuijpers, Taco W.
Matlung, Hanke L.
CANCERS, 2021, 13 (17)
[32] Therapeutic modulation of the CD47-SIRPα axis in the pediatric tumor microenvironment: working up an appetite
Gupta, Ajay
Taslim, Cenny
Tullius, Brian P.
Cripe, Timothy P.
CANCER DRUG RESISTANCE, 2020, 3 (03) : 550 - 562
[33] Functions and molecular mechanisms of the CD47-SIRPα signalling pathway
Matozaki, Takashi
Murata, Yoji
Okazawa, Hideki
Ohnish, Hiroshi
TRENDS IN CELL BIOLOGY, 2009, 19 (02) : 72 - 80
[34] Is targeting of CD47-SIRPα enough for treating hematopoietic malignancy?
Zhao, Xi Wen
Kuijpers, Taco W.
van den Berg, Timo K.
BLOOD, 2012, 119 (18) : 4333 - 4334
[35] Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis
Vaeteewoottacharn, Kulthida
Kariya, Ryusho
Pothipan, Phattarin
Fujikawa, Sawako
Pairojkul, Chawalit
Waraasawapati, Sakda
Kuwahara, Kazuhiko
Wongkham, Chaisiri
Wongkham, Sopit
Okada, Seiji
TRANSLATIONAL ONCOLOGY, 2019, 12 (02): : 217 - 225
[36] Blocking the Don't Eat Me Signal (CD47-SIRPα Axis) to Improve Antibody-Based Immunotherapy of Multiple Myeloma
Klausz, Katja
Gehlert, Carina Lynn
Boje, Ammelie Svea
Lustig, Marta
Krohn, Steffen
Ahmed, Syeda Maliha
Kellner, Christian
Valerius, Thomas
Besse, Lenka
Besse, Andrej
Driessen, Christoph
Gramatzki, Martin
Peipp, Matthias
BLOOD, 2021, 138
[37] CD47-SIRPα interactions mediate MMP expression.
Slee, J. B.
Clarke, K. A.
Levy, R. J.
Stachelek, S. J.
MOLECULAR BIOLOGY OF THE CELL, 2014, 25
[38] Mechanisms of targeting CD47-SIRPα in hematologic malignancies Response
Chao, Mark P.
Majeti, Ravindra
Weissman, Irving
BLOOD, 2012, 119 (18) : 4334 - 4335
[39] Controlling phagocyte behaviour though CD47-SIRPα interactions
Van den Berg, T. K.
Zhao, X. W.
Alvarez-Zarate, J.
Matlung, H.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 : 21 - 21
[40] Role for CD47-SIRPα signaling in xenograft rejection by macrophages
Ide, Kentaro
Wang, Hui
Tahara, Hiroyuki
Liu, Jianxiang
Wang, Xiaoying
Asahara, Toshimasa
Sykes, Megan
Yang, Yong-Guang
Ohdan, Hideki
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (12) : 5062 - 5066

← 1 2 3 4 5 →